HB 1971 requires health plans to provide reimbursement for a 12-month refill of covered prescription hormone therapy, obtained at one time, for their enrollees. This aims to increase access to these medications for patients of all ages. Starting January 1, 2026, health plans must comply, unless the enrollee requests a smaller supply, the provider instructs a smaller supply, or the therapy is a controlled substance. The 12-month supply applies to medications that can be safely stored at room temperature, while controlled substances must be covered for the maximum refill allowed by law. Prescription hormone therapy is defined as FDA-approved drugs that medically adjust hormone levels, excluding certain glucagon-like peptide-1 medications.
Substitute House Bill 1272 extends a program designed to address complex cases involving children in crisis. It maintains a children and youth multisystem care project director who oversees a rapid care team. This team's purpose is to quickly identify appropriate services and living arrangements for children who are in hospitals without medical necessity or experiencing unstable placements, facilitating their safe discharge and stable care. The bill also requires the governor to submit annual reports to the legislature detailing the program's data and recommendations.
SB 5200 exempts specific veterans' medical foster homes from state adult family home licensing requirements. This applies to homes overseen and annually reviewed by the U.S. Department of Veterans Affairs, provided they care exclusively for three or fewer veterans. However, caregivers in these exempted homes must still comply with all applicable state laws regarding training, certification, and background checks. The bill aims to clarify the regulatory framework for these specialized veteran care facilities.
SB 5182 requires the Department of Corrections to make reasonable accommodations for available midwifery and doula services for incarcerated individuals who are pregnant or have given birth within the last six weeks. It ensures that trained providers of these services are granted appropriate facility access, can assist during labor and childbirth when feasible, and can access relevant health information if authorized by the individual. The bill defines "doula services" and "midwifery services" and clarifies that the department is not required to fund or establish these services, but can adopt policy guidelines or partner with nonprofit organizations and volunteers to deliver them, ensuring they supplement routine health care.
Senate Bill 5480 aims to protect consumers by establishing new rules for medical debt. It updates the definition of "medical debt" and outlines specific provisions for how it can be handled. A central aspect of the bill makes medical debt void and unenforceable if a health care provider, facility, or collection agency unlawfully reports information about that debt to a consumer credit reporting agency. This legislation directly affects individuals with medical debt and the agencies involved in its collection and reporting.
SB 5493, titled "Concerning hospital price transparency," mandates that hospitals in Washington State increase their transparency regarding service costs. By July 1, 2027, hospitals must publish all required data and comply with federal price transparency rules (45 C.F.R. Part 180, subparts A and B, as of January 1, 2025). Starting July 1, 2027, hospitals will also be required to annually submit machine-readable files of all standard charges and consumer-friendly lists of shoppable services to the state department. This bill directly affects hospitals by requiring them to disclose pricing information, aiming to make healthcare costs more accessible to the public.
HB 1755 exempts certain hospitals that are owned or operated by a state entity from needing a "certificate of need" (CON) for elective percutaneous coronary intervention (PCI) procedures. A CON is a regulatory approval often required for healthcare facilities to offer new services or expand existing ones. This bill allows these specific state-affiliated hospitals to provide a type of heart procedure without going through that particular state approval process. The change directly affects these hospitals and the patients who receive elective PCI services there.
Senate Bill 5696 amends the law concerning a local one-tenth of one percent sales and use tax designated for chemical dependency and mental health treatment programs. The bill clarifies that funds collected from this tax may be used for the new construction of facilities and modifications to existing facilities that support these treatment and therapeutic court programs. It also affirms that these programs and their associated facility needs are considered part of local government public safety initiatives. This provides counties and cities with clear guidance on using these tax revenues for infrastructure related to these services.
SB 5355 establishes new protections and resources for student survivors of sex-based violence and harassment at Washington state's larger institutions of higher education. The bill grants survivors specific rights, including access to trauma-informed employees, a timely institutional investigation process, and mental health or counseling services. It also requires institutions to offer supportive measures, such as academic adjustments or schedule modifications, and honor court-issued no-contact orders. Additionally, the bill mandates training for Title IX employees and requires certain campuses to establish committees to evaluate and improve survivor support services.
This bill updates the law concerning contraceptive coverage for individuals enrolled in health benefit plans in Washington State. It mandates that health plans issued or renewed on or after January 1, 2026, must cover a 12-month supply of contraceptive drugs obtained at one time. This provision applies unless the enrollee requests a smaller supply or their prescribing provider instructs otherwise. The bill also allows enrollees to receive these drugs on-site at the provider's office if available and defines "contraceptive drugs" as all FDA-approved drugs used to prevent pregnancy.